MARKET WIREYahoo Finance • 12h ago
LifeMD to Report Third Quarter 2026 Financial Results on November 9Yahoo Finance report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
Why LFMD Stock slipped -1.29% Today — RQD Quant Desk Flash
$2.29 -1.29% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $2.28
LifeMD Inc. (LFMD) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $111.8M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on LFMD Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is LFMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, LifeMD Inc. (NASDAQ: LFMD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $2.29 (-1.29% 1D, market cap $111.8M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, LFMD ranks #779 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does LFMD compare to AIRS and NAKA in the Health Care sector?
▼
Within the Health Care sector (Medical/Nursing Services), LFMD carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 85.7%, and ROIC of -26.2%. By comparison, AIRS (AirSculpt Technologies Inc.) holds a E grade (33/100 RQD, P/E N/A, ROIC -7.0%, cap $120.4M) and NAKA (Nakamoto Inc.) posts a E grade (18/100 RQD, P/E N/A, ROIC -31.6%, cap $126.2M). Among the 5-stock peer group, LFMD leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for LFMD?
▼
Per LFMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000948320), LifeMD Inc. generated $194.1M in revenue (+25.3% YoY), -$11.2M in net income, and $6.4M in free cash flow against $70.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $2.28 (-0.42%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 3.3% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-11.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFMD)Realized 20D OHLCV Swing Band: ±11.6%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY LFMD SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+9/20 pts (28% of score)
SEC Form 4 / 13F Thermometer: 45% Net Buy • Disciplined Float (-0.40% YoY Shares)
▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (25% of score)
SEC XBRL FY 2025 (10-K): 3.3% FCF Margin ($6.4M FCF) & 85.7% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$2.55-11.8% Next Q
40
Q2 (-2Q)Grade E$2.25-7.6% Next Q
37
Q3 (-1Q)Grade E$2.08+10.1% Next Q
35
CurrentGrade E$2.29-9.2% Hist 90D α
32
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a LFMD Turnaround Squeeze
While LFMD currently carries a cautious 32/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.80) and Max Pain ($2.40) forces dealer call-delta covering toward $6.33.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $LFMD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LFMD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why LFMD Stock slipped -1.29% Today — RQD Quant Desk Flash
LifeMD Inc. (LFMD) slipped -1.29% to $2.29, trading at 6% of its 52-week range ($2.06 – $6.03). Stretched risk/reward at current multiples (-26% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 6% of its 52-week range ($2.06 – $6.03) with RSI-14 at 40.7 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±11.6% around $2.29 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 85.7% gross margin and $6.4M annual free cash flow.
Live LFMD Headlines & Catalysts
MARKET WIREGuruFocus • 15h ago
FEDERATED HERMES, INC. Adds LifeMD Inc (LFMD) -- Shares Look 57% Undervalued on GF ValueGuruFocus report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance UK • 18h ago
LifeMD, Inc. (LFMD) Seasonal returns chartYahoo Finance UK report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
RISK WATCHYahoo Finance • 1d ago
MDxHealth (MDXH) Stock Sees Fair Value Cut After Revenue Miss And Guidance SuspensionYahoo Finance report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 7d ago
What Medifast (MED) Said on Its Q3 Earnings CallMedifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was withi
CATALYSTYahoo Finance • 41d ago
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockNEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized a cash dividend to ho
CATALYSTYahoo Finance • 43d ago
LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber cu
MARKET WIREYahoo Finance • 47d ago
AT&T Teams Up With LifeMD for Virtual Health Care: Can it Aid Shares?T expands customer benefits with complimentary LifeMD memberships, offering virtual care, prescriptions and pharmacy services.
MARKET WIREYahoo Finance • 48d ago
AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMDYahoo Finance coverage on LFMD stock catalysts, institutional flow, and earnings outlook.
RISK WATCHYahoo Finance • 71d ago
LifeMD (LFMD) Stock Sees Fair Value Cut After Analysts Lower Targets On Weaker GuidanceLifeMD is back in focus after fair value in the updated model shifted from US$9.88 to US$8.13, an adjustment of about 18% that aligns with lower Street price targets in recent research. Analysts have been resetting expec
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LFMD)
- ✓Walkthrough of LFMD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
LFMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -55.01%🛡️ HOLDING TREND SUPPORT
2026-11-02O $2.23H $2.32L $2.23C $2.29VOL 739.7K
RES: $2.85SUP: $1.98SMA50: $2.80SMA200: $3.66
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
LFMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +25.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on LFMD today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for LFMD. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LFMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFMD)
Health Care Rank #779 of 1016
⚔️ AIRS vs LFMD Full Matrix →
1. Head-to-Head Health Care Peer Comparison (LFMD vs. AIRS, NAKA, ALPS, EUDA)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, LifeMD Inc. (LFMD) ranks #779 by composite RQD confidence (32/100, grade E) and #645 by equity capitalization ($111.8M). Within this direct 5-issuer industry benchmark cohort, LFMD leads on earnings valuation at N/A trailing P/E, while AIRS leads on capital efficiency and profitability with -7.0% ROIC and — gross margin. ALPS currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with LFMD at 32/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| LFMD
ACTIVE
LifeMD Inc. | E | 32/100 | — | 85.7% | -26.2% | -1.29% | $111.8M | Benchmark Subject |
| AIRS AirSculpt Technologies Inc. | E | 33/100 | — | — | -7.0% | +3.59% | $120.4M | /airs-vs-lfmd → |
| NAKA Nakamoto Inc. | E | 18/100 | — | — | -31.6% | -14.83% | $126.2M | /naka-vs-lfmd → |
| ALPS ALPS Group Inc Ordinary Share | D | 50/100 | — | — | — | +0.03% | $54.1M | /alps-vs-lfmd → |
| EUDA EUDA Health Holdings Limited | D- | 35/100 | — | 43.9% | -35.0% | +14.19% | $46.4M | /euda-vs-lfmd → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000948320In its most recent audited fiscal period (FY2025, filed 2025-12-31), LifeMD Inc. (LFMD) reported GAAP revenue of $194.1M (+25.3% vs. FY2024 revenue of $154.8M , and +27.2% cumulative change since FY2023) , GAAP net income of -$11.2M, operating cash flow of $8.3M, and free cash flow of $6.4M (-60.1% YoY). On the balance sheet, LFMD closed FY2025 with $70.4M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $194.1M | -$11.2M | $8.3M | $6.4M | $70.4M | — |
| FY2024 (FY) | 2024-12-31 | $154.8M | $24.5M | $17.5M | $16.0M | $76.1M | — |
| FY2023 (FY) | 2023-12-31 | $152.5M | $17.8M | $8.8M | $8.8M | — | — |
3. LFMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs LFMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, LifeMD Inc. (NASDAQ: LFMD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $2.29 (-1.29% 1D, market cap $111.8M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, LFMD ranks #779 in composite RQD confidence.
How does LFMD compare to AIRS and NAKA in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), LFMD carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 85.7%, and ROIC of -26.2%. By comparison, AIRS (AirSculpt Technologies Inc.) holds a E grade (33/100 RQD, P/E N/A, ROIC -7.0%, cap $120.4M) and NAKA (Nakamoto Inc.) posts a E grade (18/100 RQD, P/E N/A, ROIC -31.6%, cap $126.2M). Among the 5-stock peer group, LFMD leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for LFMD?
Per LFMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000948320), LifeMD Inc. generated $194.1M in revenue (+25.3% YoY), -$11.2M in net income, and $6.4M in free cash flow against $70.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is LFMD trading relative to its 50-day, 200-day, and 52-week technical levels?
LFMD last traded at $2.29 (-1.29% on volume of 599,137 shares), positioning the stock -18.21% below its 50-day simple moving average ($2.80) and -37.43% below its 200-day simple moving average ($3.66). Across its 52-week range of $2.06 to $6.03, LFMD sits at the 5.8% percentile with a 14-day RSI of 40.7 (NEUTRAL RANGE) and an implied next-earnings move of ±11.6% ($2.02 to $2.56).
LFMD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is LFMD stock moving today?
Why LFMD Stock slipped -1.29% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-26% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 32/100 (E)
✓ STAGE-C NUMBER FIREWALL VERIFIED
LFMD — LifeMD Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:43:39Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, LifeMD Inc. carries an RQD Score of 32 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars, each scored out of 20, are: Fundamental Cash Engine 8 (ROIC -26.2%; FCF yield 5.73%); Whale 13F Flow 3 (institutional accumulation and options positioning); Insider Conviction 9 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit 7 (Beta 1.0; sector sensitivity); and Forensic Balance Sheet 5 (Altman Z 0.2; Piotroski F 6/9; Debt/Equity 0.5). For a prospective investor, the weakest pillar relative to its ceiling is whale/institutional flow, while the forensic balance sheet pillar signals elevated distress risk as reflected in the low Altman Z. The most constructive element is the positive FCF yield of 5.73%, which is a cash-generation datapoint but is offset by negative ROIC. The rating frames the stock as a forensic-risk name; any valuation tradeoff (for example, a low absolute share price against a 52-week range of $2.06 - $6.03) should be weighed against the balance-sheet and returns signals rather than the price alone. This is educational analysis, not personalized advice.
Recent Catalysts & News Wire Analysis
- Earnings timing (YELLOW): LifeMD is scheduled to report third-quarter 2026 financial results on November 9, per the news wire.
- Institutional activity (YELLOW): A report notes that Federated Hermes, Inc. added LifeMD shares, citing a GuruFocus fair-value estimate that the shares look 57% undervalued; this reflects a third-party valuation view, not a confirmed fundamental figure.
- Risk watch (RED): A Yahoo Finance item flagged a fair value cut for MDxHealth (MDXH) after a revenue miss and guidance suspension. This item concerns a different issuer and is tagged as relevant to LFMD only through the wire's related-symbol field; it is a sector-sentiment signal rather than a direct LifeMD event.
- Seasonal chart (YELLOW): A Yahoo Finance UK seasonal returns chart was published; no quantitative content is provided in the source.
Per the Butterfly Supply-Chain Graph, the supply chain is NONE, with no butterfly links and no proprietary signals.
Open Questions
- What are LifeMD's specific products, customer base, and revenue mix behind the reported $194.1M in FY 2025 revenue?
- What are the period-end cash and debt balances, which are N/A or not provided in most reported periods?
- What drove the swing from FY 2024 net income of $24.5M to FY 2025 net income of $-11.2M?
- What is the actual EPS and what are the P/E and EV/EBITDA multiples, given their absence from the source?
- What do the insider, 13F, and Congressional flows underlying the RQD pillar scores actually consist of?
LFMD Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for LifeMD Inc. (LFMD) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 12h ago
LifeMD to Report Third Quarter 2026 Financial Results on November 9 Yahoo Finance report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GuruFocus • 15h ago
FEDERATED HERMES, INC. Adds LifeMD Inc (LFMD) -- Shares Look 57% Undervalued on GF Value GuruFocus report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance UK • 18h ago
LifeMD, Inc. (LFMD) Seasonal returns chart Yahoo Finance UK report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Yahoo Finance • 1d ago
MDxHealth (MDXH) Stock Sees Fair Value Cut After Revenue Miss And Guidance Suspension Yahoo Finance report covering LifeMD Inc. (LFMD) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo • 7d ago
What Medifast (MED) Said on Its Q3 Earnings Call Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was withi
🟢 CATALYST Yahoo Finance • 41d ago
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized a cash dividend to ho
🟢 CATALYST Yahoo Finance • 43d ago
LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients? LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber cu
🟡 MARKET WIRE Yahoo Finance • 47d ago
AT&T Teams Up With LifeMD for Virtual Health Care: Can it Aid Shares? T expands customer benefits with complimentary LifeMD memberships, offering virtual care, prescriptions and pharmacy services.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
LFMD Bull vs. Bear Conversation Board — What's Your Call at $2.29?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON LFMD 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $2.04 (-12.1%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is LFMD (E • RQD 32/100) a Buy at $2.32?
Welcome to the LFMD (LifeMD Inc.) Roar Pit. Current RQD Composite is 32/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Medical/Nursing Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
FO ForensicBear Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $1.95 (-15.9%)
Spot @ $2.32 Pump the brakes on LFMD — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on LFMD, but look at what you are paying: current EV/EBITDA multiples with 85.7% gross margins. Unless LifeMD Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH
🎯 Target: $2.88 (+24.1%)
Spot @ $2.32 LFMD cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on LFMD, the market is fixating on short-term headline noise in Medical/Nursing Services and ignoring the balance sheet and cash flow trajectory. At $2.32 (52-wk range $2.06 - $6.03), any beat on forward guidance forces shorts and underweight funds to chase.